SCHEMBL18326161

SCHEMBL18326161

c1ccc(-c2ccc(N(c3ccc(-c4ccc5c(c4)oc4ccccc45)cc3)c3ccc(C4(c5ccccc5)c5ccccc5-c5ccccc54)cc3)cc2)cc1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MMP12 P39900 1/20 0.37
MMP13 P45452 1/20 0.37
MEN1 O00255 3/20 0.35
MAPT P10636 3/20 0.35
KMT2A Q03164 3/20 0.35
KDM4E B2RXH2 2/20 0.35
SMN1; SMN2 Q16637 2/20 0.35
LMNA P02545 1/20 0.35
OPRK1 P41145 1/20 0.35
AHR P35869 2/20 0.35
HPGD P15428 2/20 0.34
ALDH1A1 P00352 1/20 0.34
PLA2G2A P14555 4/20 0.34
PLA2G4A P47712 4/20 0.34
HCRTR1 O43613 1/20 0.33
NPC1 O15118 2/20 0.33
RAB9A P51151 2/20 0.33
ATM Q13315 1/20 0.33
PDK2 Q15119 1/20 0.33
ALOX5 P09917 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18326168 1.00 MMP12 (0.37) MMP12MMP13MEN1MAPTKMT2A
SCHEMBL18326179 0.98 MMP12 (0.36) MMP12MMP13MEN1MAPTKMT2A
SCHEMBL25814653 0.95 MMP12 (0.36) MMP12MMP13MEN1MAPTKMT2A
SCHEMBL24255914 0.94 MMP12 (0.35) MMP12MMP13MEN1MAPTKMT2A
SCHEMBL18326178 0.94 MMP12 (0.35) MMP12MMP13MEN1MAPTKMT2A
SCHEMBL17827438 0.94 PLA2G2A (0.35) MMP12MMP13MEN1MAPTKMT2A
SCHEMBL16631193 0.94 MEN1 (0.36) MMP12MMP13MEN1MAPTKMT2A
SCHEMBL17827430 0.94 MEN1 (0.36) MMP12MMP13MEN1MAPTKMT2A
SCHEMBL21925025 0.93 MMP12 (0.35) MMP12MMP13MEN1MAPTKMT2A
SCHEMBL17855735 0.93 MMP12 (0.36) MMP12MMP13MEN1MAPTKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11563179-B2 Compound, organic optoelectronic element comprising same and display device thereof SAMSUNG SDI CO., LTD. (KR) 2023-01-24 US disclosed
EP-3144301-A1 COMPOUND, ORGANIC OPTOELECTRONIC ELEMENT COMPRISING SAME AND DISPLAY DEVICE THEREOF Samsung SDI Co., Ltd. (KR) 2017-03-22 EP disclosed
US-20160372666-A1 COMPOUND, ORGANIC OPTOELECTRONIC ELEMENT COMPRISING SAME AND DISPLAY DEVICE THEREOF SAMSUNG SDI CO., LTD. (KR) 2016-12-22 US disclosed
US-20160372666-A1 COMPOUND, ORGANIC OPTOELECTRONIC ELEMENT COMPRISING SAME AND DISPLAY DEVICE THEREOF SAMSUNG SDI CO., LTD. (KR) 2016-12-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160372666-A1 COMPOUND, ORGANIC OPTOELECTRONIC ELEMENT COMPRISING SAME AND DISPLAY DEVICE THEREOF OR10J3, OR51E2, ORMDL3 MMP12 3242/4885MMP13 4532/4885MEN1 958/4885
US-11563179-B2 Compound, organic optoelectronic element comprising same and display device thereof OR10J3, OR51E2, ORMDL3 MMP12 3242/4885MMP13 4532/4885MEN1 958/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.